Immunogenicity and efficacy of chimeric dengue vaccine (DENVax) formulations in interferon-deficient AG129 mice
2011/12/13 by Joseph N. Brewoo, Richard M. Kinney, Tim D. Powell +8 · 25 citations
Medicine · #Mosquito-borne diseases and control #Viral Infections and Vectors #Viral Infections and Outbreaks Research
paper · doi:10.1016/j.vaccine.2011.11.072
Citations
Cited by
- Current progress in dengue vaccines. [europepmc]
- Understanding the dengue viruses and progress towards their control. [europepmc]
- Dengue vaccines: recent developments, ongoing challenges and current candidates. [europepmc]
- Mouse models to study dengue virus immunology and pathogenesis. [europepmc]
- Safety and immunogenicity of a recombinant live attenuated tetravalent dengue vaccine (DENVax) in flavivirus-naive healthy adults in Colombia: a randomised, placebo-controlled, phase 1 study. [europepmc]
- Investigating the efficacy of monovalent and tetravalent dengue vaccine formulations against DENV-4 challenge in AG129 mice. [europepmc]
- Flaviviruses, an expanding threat in public health: focus on dengue, West Nile, and Japanese encephalitis virus. [europepmc]
- Safety and Immunogenicity of a Live Attenuated Tetravalent Dengue Vaccine Candidate in Flavivirus-Naive Adults: A Randomized, Double-Blinded Phase 1 Clinical Trial. [europepmc]
- Mouse models of dengue virus infection for vaccine testing. [europepmc]
- Efficacy of a Trivalent Hand, Foot, and Mouth Disease Vaccine against Enterovirus 71 and Coxsackieviruses A16 and A6 in Mice. [europepmc]
- Tackling dengue fever: Current status and challenges. [europepmc]
- Vaccines licensed and in clinical trials for the prevention of dengue. [europepmc]
- Which Dengue Vaccine Approach Is the Most Promising, and Should We Be Concerned about Enhanced Disease after Vaccination? There Is Only One True Winner. [europepmc]
- Plant-expressed Fc-fusion protein tetravalent dengue vaccine with inherent adjuvant properties. [europepmc]
- Dengue vaccine-induced CD8+ T cell immunity confers protection in the context of enhancing, interfering maternal antibodies. [europepmc]
- Zika virus like particles elicit protective antibodies in mice. [europepmc]
- Efficient Delivery of Dengue Virus Subunit Vaccines to the Skin by Microprojection Arrays. [europepmc]
- Humanized Mice in Dengue Research: A Comparison with Other Mouse Models. [europepmc]
- A Review on Dengue Vaccine Development. [europepmc]
- Two Is Better Than One: Evidence for T-Cell Cross-Protection Between Dengue and Zika and Implications on Vaccine Design. [europepmc]
- Challenges in Dengue Vaccines Development: Pre-existing Infections and Cross-Reactivity. [europepmc]
- Anti-dengue Vaccines: From Development to Clinical Trials. [europepmc]
- A single-dose live attenuated chimeric vaccine candidate against Zika virus. [europepmc]
- Mammalian animal models for dengue virus infection: a recent overview. [europepmc]
- Current Development and Challenges of Tetravalent Live-Attenuated Dengue Vaccines. [europepmc]